Publication

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Related publications (81)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Graph Chatbot

Chat with Graph Search

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade

The selective Tie2 inhibitor rebastinib blocks recruitment and function of Tie2Hi macrophages in breast cancer and neuroendocrine pancreatic tumors

Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment

Expression proteomics study to determine metallodrug targets and optimal drug combinations

Precision targeting of tumor macrophages with a CD206 binding peptide

A novel method for sensitive microRNA detection: Electropolymerization based doping

Microfluidic-assisted chromogenic in situ hybridization (MA-CISH) for fast and accurate breast cancer diagnosis

A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response

Engineering Lymphangiogenesis

Stratification and therapeutic potential of PML in metastatic breast cancer